Our UHN programs and services are among the most advanced in the world. We have grouped our physicians, staff, services and resources into 10 medical programs to meet the needs of our patients and help us make the most of our resources.
University Health Network is a health care and medical research organization in Toronto, Ontario, Canada. The scope of research and complexity of cases at UHN has made us a national and international source for discovery, education and patient care.
Our 10 medical programs are spread across eight hospital sites – Princess Margaret, Toronto General, Toronto Rehab’s five sites, Toronto Western – as well as our education programs through the Michener Institute of Education at UHN. Learn more about the services, programs and amenities offered at each location.
Maps & Directions
Find out how to get to and around our nine locations — floor plans, parking, public transit, accessibility services, and shuttle information.
Ways You Can Help
Being touched by illness affects us in different ways. Many people want to give back to the community and help others. At UHN, we welcome your contribution and offer different ways you can help so you can find one that suits you.
The Newsroom is the source for media looking for information about UHN or trying to connect with one of our experts for an interview. It’s also the place to find UHN media policies and catch up on our news stories, videos, media releases, podcasts and more.
A recent study led by Drs.
Tereza Martinu and
Bryan Coburn at Toronto General Hospital Research Institute looked at how chronic acid reflux – known as gastroesophageal reflux disease – affects the communities of microbes found in the lung.
The composition of microbial communities in the lung after transplantation differs between people and can be associated with lung dysfunction and inflammation.
"We wondered whether chronic reflux changed the microbial community, or microbiota, in the lung after transplantation," says Dr. Martinu.
To explore the effect of chronic reflux on lung health after transplantation, the research team compared samples of lung microbiota from individuals who received a lung transplant between 2010 and 2015. Of these individuals, 24 of them experienced chronic acid reflux in the first year after transplant and 51 did not.
Analyses of the data revealed that the density and diversity of the microbial community differed in those with chronic reflux, compared to those without reflux. However, those with the condition were not more likely to experience inflammation and dysfunction of the lung.
When the team considered all samples from the 75 individuals that participated in the study, they identified three different types of microbial community profiles: the first type had high bacterial density, with species that are commonly found in the mouth. The second type had low bacterial density. And the third type had varying densities but with species that often cause infectious disease. This third type was more likely to be associated with lung inflammation and dysfunction.
Individuals with chronic acid reflux were more likely to have the first type of profile.
"We found that patients with chronic reflux had increased bacterial density with more species that are commonly found in the mouth," says Dr. Martinu, who is also a lung transplant physician at UHN's Ajmera Transplant Centre and associate professor of Medicine at the University of Toronto (U of T). "Despite having higher levels of bacteria, these individuals did not experience more lung dysfunction than those without chronic reflux in general."
"Chronic acid reflux is an important modulator of the microbial community in the lung after transplantation. Future studies of chronic reflux in the context of transplantation should include the microbial community profile as part of the assessment," concludes Dr. Coburn, who is also an assistant professor of Laboratory Medicine & Pathobiology at the U of T.
Rapid tests for lung microbiota may be useful predictors of disease to help lung transplant recipients manage their health in the future.
This work was supported by the Canadian Institutes of Health Research, UHN's Ajmera Transplant Centre, U.S. National Institutes of Health, Comprehensive Research Experience for Medical Students Program, Cystic Fibrosis Foundation and UHN Foundation.